NDUFS1 and cancer: We speculated that although the increase in ROS by doxorubicin or cisplatin would facilitate cell death in the majority of A549 cancer cells, it could potentially increase Ndufs1 oxidation, and subsequently the formation of ETC supercomplexes in a small subset of cells, facilitating chemoresistance.